chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX280121C00022000
IBRX Jan 21 2028 22.00 Call
optionOPRA

EODOct 16, 2026
1.30USD-18.750%(-0.30)185Vol8,022OI
Loading…
Underlying
IBRX
Underlying Price
$8.48
Type
Call
Strike
22
Expiration
Jan 21, 2028
DTE
458d
Moneyness
OTM
Intrinsic
$0.00
IBRX 22 Call Across Expirations
ExpirationDTELastChangeVolOpen Int
Jan 15, 202787d$0.25-3.85%357,812
Jan 21, 2028458d$1.30-18.75%1858,022
IBRX Nearby Strikes · Jan 21, 2028
StrikeLastChangeVolOpen IntMoneyness
7.5 C$4.20-10.64%9,83118,015ITM
10 C$3.20-14.44%67710,691OTM
12 C$2.70-20.59%161,740OTM
15 C$2.80+3.70%537,866OTM
17 C$2.82+4.44%301,006OTM
20 C$1.50-23.08%461,671OTM
22 C$1.30-18.75%1858,022OTM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.